Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IPAB Members Will Be Named In Time To Begin Recommendations In 2014, Sebelius Says

This article was originally published in The Pink Sheet Daily

Executive Summary

The White House has begun discussions with potential board member nominees, HHS secretary tells House Energy and Commerce Health Subcommittee.

You may also be interested in...



IPAB Back In The Spotlight As Repeal Bill Clears House Subcommittee

House Energy and Commerce health panel votes to repeal IPAB; Ways and Means Committee plans a hearing in early March.

Cost-Effectiveness Colors ACIP Decision On Hep B Vaccination For Diabetics

The Centers for Disease Control’s Advisory Committee on Immunization Practices limited its Oct. 25 recommendation for vaccinating adult diabetics against hepatitis B to those under 60 years of age because of cost effectiveness considerations.

Cost-Effectiveness Colors ACIP Decision On Hep B Vaccination For Diabetics

The Centers for Disease Control’s Advisory Committee on Immunization Practices limited its Oct. 25 recommendation for vaccinating adult diabetics against hepatitis B to those under 60 years of age because of cost effectiveness considerations.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS072511

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel